Acorda Therapeutics | Spinal Cord Injury Zone!

Acorda Therapeutics Announces Initiation of Phase 2 Trial of Treatment for Spinal Cord Injury

September 25, 2013

AC105 improved motor function after spinal cord injury in preclinical studies ARDSLEY, N.Y.--(BUSINESS WIRE)--Sep. 25, 2013-- Acorda Therapeutics, Inc. (Nasdaq:ACOR) today announced that the first...

Working2Walk 2011, Anthony Caggiano (Acorda)

October 24, 2011

The Challenges of Chondroitinase Development for Spinal Cord Injury

The mission of The Spinal Cord Injury Zone is to archive important Spinal Cord Injury News and Spinal Cord Injury Information for education and awareness. The Spinal Cord Injury Zone website is a not-for-profit Spinal Cord Injury educational Knowledge Base.

Tag: Acorda Therapeutics

Acorda Therapeutics Announces Initiation of Phase 2 Trial of Treatment for Spinal Cord Injury

Working2Walk 2011, Anthony Caggiano (Acorda)